This court decision is consistent with the fundamental principle that patent laws exist to support and encourage medical innovators, not undermine them.

288

Revenues in the third quarter of 2005 reflected lower prescription growth and increased competition in key therapeutic markets in the U.S., such as the lipid-lowering market, where the rate of growth in the third quarter declined significantly versus the first half of the year; and the erectile dysfunction market, which has been in decline compared to 2004.

183

This is a normal part of our planning cycle, ... You should have as much confidence in us this week as you had last week.

148

Lipitor is one of the most important medical breakthroughs of our era, and millions of patients have used it to lower their cholesterol. This court decision is consistent with the fundamental principle that patent laws exist to support and encourage medical innovators, not undermine them.

138

We are evaluating our financial prospects in light of current and anticipated business conditions and are withdrawing our prior guidance.

128

We are evaluating our financial prospects for 2006 and 2007 in light of current and anticipated business conditions, and are withdrawing our prior guidance for those years.

110